Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA
by WannabeRockstar
seroconversion. and genetically linked HCV infect...
Aptima HCV RNA Qualitative Assay
Aptima HCV RNA Qualitative Assay
by delilah
Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 ...
Update on the HCV Antiviral Pipeline
Update on the HCV Antiviral Pipeline
by natalia-silvester
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
Hepatitis C Virus HCV Infection Testing for Diagnosis31
Hepatitis C Virus HCV Infection Testing for Diagnosis31
by joanne
Conrmed Unconrmed Unconrmed ...
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
by jesse588
Mandatory criteria: . Probability based sampling. ...
The Role of Diagnostics in the Management of HCV and HIV
The Role of Diagnostics in the Management of HCV and HIV
by zoe
Presented by: Thomas E. Burgess, PhD, DABCC, FAACC...
HIV-HCV Coinfection in the era of effective antiviral therapy
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
Management of HCV in Co-Infected Patients
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
AIDS CARE GROUP Grace Paik, CRNP
AIDS CARE GROUP Grace Paik, CRNP
by marina-yarberry
Regina . Ubaldi. -Rosen, CRNP. ELLAH NOTA, CRNP. ...
Newest Drugs for Hepatitis C
Newest Drugs for Hepatitis C
by tawny-fly
Matthew Luu, Yuan Fang (Pearl) Cai, Shiming Sun, ...
Hepatitis C Genotyping using a Line Probe Assay
Hepatitis C Genotyping using a Line Probe Assay
by sterialo
Carolyn A. Ragland. August 2008 . Hepatitis C. *. ...
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
by christina
for Hepatitis C Virus Diagnosis: Usefulness among...
Case diagnosis criteria b
Case diagnosis criteria b
by finley
ased on 2012 Council for State and Territorial Ep...
Hepatitis C Dr. Alipour
Hepatitis C Dr. Alipour
by beatrice
Chronic hepatitis C virus (HCV) infection is one o...
Table 4-1. Interpretation of hepatitis C laboratory results
Table 4-1. Interpretation of hepatitis C laboratory results
by bethany
Test. . Outcome*. Interpretation†. Further. . ...
Figure 4-3. Process for perinatal hepatitis C case ascertainment and classification
Figure 4-3. Process for perinatal hepatitis C case ascertainment and classification
by lam
*Test. . results. . among infants. . <2 mont...
Marion G. Peters, MD John V. Carbone, MD, Endowed Chair
Marion G. Peters, MD John V. Carbone, MD, Endowed Chair
by ashley
Professor of Medicine. Chief of Hepatology Researc...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
2014: HIV, HCV, and HBV
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
Taking Steps to Improve the Management
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
H. Nina Kim, MD Assistant Professor of Medicine
H. Nina Kim, MD Assistant Professor of Medicine
by giovanna-bartolotta
Division of Infectious Diseases. University of Wa...
HIV and viral hepatitis co-infection
HIV and viral hepatitis co-infection
by cheryl-pisano
Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...
OBV/PTV/r DSV RBV OBV/PTV/r
OBV/PTV/r DSV RBV OBV/PTV/r
by ellena-manuel
DSV . placebo. Randomisation*. Partial blind. 1...
ALLY-2
ALLY-2
by aaron
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
ALLY-2
ALLY-2
by tawny-fly
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
LDV/SOF 90/400 mg
LDV/SOF 90/400 mg
by aaron
qd. Non-randomised. Open-label. N =. 21. W12. SV...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Arthur Y. Kim, MD
Arthur Y. Kim, MD
by stefany-barnette
Assistant Professor of Medicine. Harvard Medical ...
TURQUOISE-I
TURQUOISE-I
by marina-yarberry
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
TURQUOISE-II
TURQUOISE-II
by pasty-toler
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Boceprevir in Treatment Experienced
Boceprevir in Treatment Experienced
by tatiana-dople
RESPOND-2. Phase . 3. Treatment. . Experienced. ...
Treatment of Hepatitis C in patients with
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Edited by
Edited by
by celsa-spraggs
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
TURQUOISE-I
TURQUOISE-I
by natalia-silvester
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
TURQUOISE-II
TURQUOISE-II
by giovanna-bartolotta
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Edited by
Edited by
by luanne-stotts
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Current strategies for the management of treatment naïve a
Current strategies for the management of treatment naïve a
by min-jolicoeur
Mark S. Sulkowski, MD. Medical Director, Viral He...
CURRY
CURRY
by faustina-dinatale
Design. Open-label. CURRY . Study. : SOF + RBV fo...